The Administrative Core provides the leadership and organizational structure to support the efforts of the 174 researchers who are members of the CFAR. The primary mission of the Core is to foster collaboration, communication, and synergy between CFAR members at the institutions we serve - the Case Western Reserve University (CWRU) School of Medicine, the Case Medical Center (University Hospitals of Cleveland), MetroHealth Medical Center, the Cleveland Clinic Foundation and the Joint Clinical Research Center (JCRC) in Kampala Uganda. The Core also oversees and assesses the work of the Developmental Core and the four laboratory cores (Uganda Laboratory Core;Clinical Services;Virology, Proteomics &Microbial Pathogenesis;Immune Function). The Administrative Core is the guiding force for building the CFAR's capacity to realize its full scientific potential and successfully achieve its goals. The Core has developed a thoughtful and responsive Strategic Planning process, fiscal controls for the CFAR shared resource Cores, outreach programs to inform CFAR investigators of recent progress and events, community outreach programs, and methods to foster cross-CFAR linkages, and pursue new research opportunities that will benefit our community of HIV/AIDS investigators.
The Specific Aims of the Case CFAR Administrative Core A are: ? Providing overall leadership and an administrative structure that fosters communication and collaboration among CFAR members ? Ensuring sound fiscal management of the CFAR shared research cores, developmental funds, and discretionary funds granted to the CFAR Director by our institutions. ? Maintaining appropriate operational management of the CFAR and generating reports as needed. ? Providing an effective mechanism for strategic planning and evaluation of center operational activities. ? Promoting interdisciplinary collaboration among CFAR researchers, and supporting collaborative research programs among CFARs in the national network and industry. ? Sponsoring HIV/AIDS-related educational programs, seminar series and symposia. ? Facilitating the training of underserved minorities in HIV research and participating in educational programs directed towards increased community awareness of HIV/AIDS.

Agency
National Institute of Health (NIH)
Type
Center Core Grants (P30)
Project #
5P30AI036219-20
Application #
8641299
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
20
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Freeman, Michael L; Lederman, Michael M; Gianella, Sara (2016) Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection. Curr HIV/AIDS Rep 13:10-9
Veazey, R S; Pilch-Cooper, H A; Hope, T J et al. (2016) Prevention of SHIV transmission by topical IFN-β treatment. Mucosal Immunol 9:1528-1536
Hirsch, Christina S; Rojas, Roxana; Wu, Mianda et al. (2016) Mycobacterium tuberculosis Induces Expansion of Foxp3 Positive CD4 T-cells with a Regulatory Profile in Tuberculin Non-sensitized Healthy Subjects: Implications for Effective Immunization against TB. J Clin Cell Immunol 7:
Althoff, Keri N; Rebeiro, Peter F; Hanna, David B et al. (2016) A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts. J Int AIDS Soc 19:20707
Hrecka, Kasia; Hao, Caili; Shun, Ming-Chieh et al. (2016) HIV-1 and HIV-2 exhibit divergent interactions with HLTF and UNG2 DNA repair proteins. Proc Natl Acad Sci U S A 113:E3921-30
Valadkhan, Saba; Gunawardane, Lalith S (2016) lncRNA-mediated regulation of the interferon response. Virus Res 212:127-36
Reyes-Rodriguez, Angel L; Reuter, Morgan A; McDonald, David (2016) Dendritic Cells Enhance HIV Infection of Memory CD4(+) T Cells in Human Lymphoid Tissues. AIDS Res Hum Retroviruses 32:203-10
Li, Jonathan Z; Etemad, Behzad; Ahmed, Hayat et al. (2016) The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption. AIDS 30:343-53
Gianella, Sara; Letendre, Scott (2016) Cytomegalovirus and HIV: A Dangerous Pas de Deux. J Infect Dis 214 Suppl 2:S67-74
Klein, Marina B; Althoff, Keri N; Jing, Yuezhou et al. (2016) Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. Clin Infect Dis 63:1160-1167

Showing the most recent 10 out of 435 publications